These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36543294)

  • 21. Chitosan-Albumin Nanocomposite as a Promising Nanocarrier for Efficient Delivery of Fluconazole Against Vaginal Candidiasis.
    Hatamiazar M; Mohammadnejad J; Khaleghi S
    Appl Biochem Biotechnol; 2024 Feb; 196(2):701-716. PubMed ID: 37178249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental pH influences Candida albicans biofilms regarding its structure, virulence and susceptibility to fluconazole.
    de Vasconcellos AA; Gonçalves LM; Del Bel Cury AA; da Silva WJ
    Microb Pathog; 2014; 69-70():39-44. PubMed ID: 24685701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains.
    R M Machado GD; Pippi B; Dalla Lana DF; Amaral AP; Teixeira ML; Souza KC; Fuentefria AM
    Pharm Biol; 2016 Nov; 54(11):2410-2419. PubMed ID: 27050162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel antifungal triazoles with alkynyl-methoxyl side chains: Design, synthesis, and biological activity evaluation.
    Xie F; Hao Y; Li L; Wang R; Bao J; Chi X; Monk BC; Wang T; Yu S; Jin Y; Zhang D; Ni T; Yan L
    Eur J Med Chem; 2023 Sep; 257():115506. PubMed ID: 37216811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 27. Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of
    Li X; Zhao Y; Huang X; Yu C; Yang Y; Sun S
    Front Cell Infect Microbiol; 2017; 7():124. PubMed ID: 28439502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against
    Kamli MR; Alzahrani EA; Albukhari SM; Ahmad A; Sabir JSM; Malik MA
    J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay.
    Barad S; Roudbary M; Omran AN; Daryasari MP
    Bratisl Lek Listy; 2017; 118(3):169-174. PubMed ID: 28319414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
    Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azobenzene derivatives with activity against drug-resistant Candida albicans and Candida auris.
    Raschig M; Ramírez-Zavala B; Wiest J; Saedtler M; Gutmann M; Holzgrabe U; Morschhäuser J; Meinel L
    Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200463. PubMed ID: 36403201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Effects and Mechanisms of Budesonide in Combination with Fluconazole against Resistant Candida albicans.
    Li X; Yu C; Huang X; Sun S
    PLoS One; 2016; 11(12):e0168936. PubMed ID: 28006028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens.
    Zhang JD; Cao YB; Xu Z; Sun HH; An MM; Yan L; Chen HS; Gao PH; Wang Y; Jia XM; Jiang YY
    Biol Pharm Bull; 2005 Dec; 28(12):2211-5. PubMed ID: 16327151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against
    Chen X; Shi Y; Li Y; Su S; Wang P; Sun S
    Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.